Back to Success Stories

Emteq Labs

Dr Charles Nduka is a consultant plastic and reconstructive surgeon with a specialist interest in facial palsy. Seeing first-hand how his patients struggled to retrain their facial muscles after reconstructive surgery, often reinforcing the wrong movements without knowing it, he began to ask a simple but powerful question. How do you give people actionable information about their own behaviour to improve their lives? That question became the founding principle of Emteq Labs, using sensors embedded in VR headsets and smart glass technology to track and change the everyday behaviours that shape our long-term health.

Emteq Team working on their VR product

The Challenge

Deep tech rarely follows a straight line to market. For Emteq, the core technology was always sound, but translating a compelling clinical application into a commercially investable proposition proved to be a long and winding road. Early conversations with investors surfaced a familiar tension: many were looking for near-term revenue and a mass-market addressable audience, at a time when Emteq was still doing foundational R&D. Facial palsy, despite the real unmet need it represented, was seen by some investors as too niche, even as the evidence suggested that starting niche is precisely how many of the world’s most successful companies found their footing.

Over the past decade whilst tenants at Sussex Innovation, the team has continued to develop the platform while navigating shifting market conditions, the rise and plateau of consumer VR, and an ever-evolving funding landscape. What sustained them was a firm belief in their first principles: that smart glasses would become the next major interaction platform beyond the smartphone, and that continuous, passive sensing of human behaviour could unlock entirely new approaches to health and wellbeing.

Sussex-based engineer testing electronic components at innovation hub

Our Solution

Sussex Innovation’s relationship with the University of Sussex has long been one of its most valuable assets for members working at the frontier of deep tech. For Emteq, it proved pivotal in unlocking the grant funding needed to keep development moving forward. The company has formed deep connections to the University during its time on campus, with their CTO and Head of Hardware both coming from postgraduate courses at Sussex.

A chance conversation between Dr Nduka and Sussex Innovation’s Head of University Services, Peter Lane, led to an introduction to Prof Martin Yeomans, a researcher who had dedicated much of his career trying to find a practical way to monitor dietary behaviour in the real world. Emteq’s team had observed that the sensors in their glasses could detect the muscle activity associated with chewing, and Prof Yeomans immediately recognised the significance.

He and the University’s Innovation and Business Partnerships team worked directly with Emteq to develop an Accelerated Knowledge Transfer project with funding from Innovate UK, and continued the collaboration using Higher Education Innovation Funding. Further validation work, funded by UKRI via its Consumer Lab scheme at Bristol University, resulted in a published paper demonstrating that the technology could track dietary behaviours in real time and, crucially, change them.

Woman wearing Emteq smart glass

The Outcome

The research validated something that Emteq had long believed: that the most powerful use cases for their technology lay in helping people understand and reshape the everyday behaviours – eating habits, attention, emotional responses – that quietly shape their long-term health. With peer-reviewed evidence in hand and a growing body of real-world validation, the proposition is now substantially de-risked for institutional investors in a way that was simply not possible at the outset.

Emteq has been granted 31 patents along its development journey to date, winning funding and awards from the National Institute for Health Research and EU Horizon 2020 alongside Innovate UK. Smart glasses have gone from a novelty to a mainstream product category, with over ten million devices sold in the past year alone. The market has, in Charles’s words, finally caught up with Emteq’s thesis.

Dr Charles Nduka

“We’ve almost come full circle, back to the same question we were originally trying to answer with facial palsy: what is it you’re doing every day that’s damaging your health? An estimated 80% of premature deaths are behaviourally mediated, so there’s real impact to any early intervention we can make using our hardware to help people understand their habits better.”

Dr Charles Nduka – Founder and CSO, Emteq Labs
Emteq smart glasses in development in Sussex

For deep tech founders willing to stay the course, the combination of grant funding, academic collaboration, and a clear-eyed view of the long game can make all the difference. If you’re developing a deep tech innovation and looking for the funding and connections to take it from research to investment-ready, our team understands both the journey, and the Sussex ecosystem to help you make it.

Dr Charles Nduka

“Investors, in many cases, have a certain perspective about how big companies start. What we’re developing is deep technology, and as such it takes time, it takes research, it takes resources, and it takes patience. We’re part of an environment and a community here that properly understands those realities.”

Dr Charles Nduka – Founder and CSO, Emteq Labs